Last updated: July 11, 2026

Application No. 19/425,966

Untitled Application

Unknown

Filed

Priority

Dec 30, 2015 — provisional 62/272,965 +3 more

Examiner

DRAPER, LESLIE A ROYDS

Art Unit

Tech Center

Genentech, Inc.

Assignee

Genentech Inc.

OA Round

1 (Non-Final)

This examiner grants 27% of cases after interview

— +43.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 785 resolved cases, 2023–2026

Examiner Intelligence

DRAPER, LESLIE A ROYDS View full profile →

Grants only 27% of cases

Career Allowance Rate

215 granted / 785 resolved

-32.6% vs TC avg

Strong +43% interview lift

Without

With

+43.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 9m

Avg Prosecution

10 currently pending

Career history

818

Total Applications

across all art units

Statute-Specific Performance

§101

0.3%

-39.7% vs TC avg

§103

13.5%

-26.5% vs TC avg

§102

75.3%

+35.3% vs TC avg

§112

2.8%

-37.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 785 resolved cases

Prosecution Timeline

Apr 03, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/330,987

Patent 12616685

CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATOR RELACORILANT AND CYP2C9 SUBSTRATES

4y 11m to grant Granted May 05, 2026

17/607,475

Patent 12605381

METHOD FOR TREATING ENDOMETRIOSIS-ASSOCIATED PAIN BY USING DIAMINOPYRIMIDINE COMPOUND

4y 5m to grant Granted Apr 21, 2026

18/423,029

Patent 12599602

METHODS FOR TREATING CHOLESTASIS

2y 2m to grant Granted Apr 14, 2026

17/271,793

Patent 12582644

O-GLCNAC TRANSFERASE INHIBITORS AND USES THEREOF

5y 0m to grant Granted Mar 24, 2026

17/595,332

Patent 12570651

QUINAZOLINE-2,4-DIONE DERIVATIVES AS PARP INHIBITORS

4y 3m to grant Granted Mar 10, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

27%

Grant Probability

71%

With Interview (+43.3%)

3y 9m

Median Time to Grant

Low

PTA Risk

Based on 785 resolved cases by this examiner. Grant probability derived from career allowance rate.